Source: BioSpace

Seventure: Citryll completes 18.5 M fundraise to develop CIT-013, an antibody targeting Neutrophil Extracellular Traps

Citryll announced it closed a total fundraise of € 18.5 million, led by Seventure, co-led by BioGeneration Ventures with existing investors BOM Brabant Ventures, BrightGene and ModiQuest contributing to this round.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Isabelle De Cremoux's photo - CEO of Seventure

CEO

Isabelle De Cremoux

CEO Approval Rating

68/100

Seventure focuses on early to high growth life sciences, information technology and communication sectors. Read more